Skip to main content
. 2015 Jul 29;2015(7):CD007399. doi: 10.1002/14651858.CD007399.pub2

Dunn 2011.

Methods Prospective non‐blinded randomized trial
Participants Adults aged 16‐65 years, with shoulder dislocation
Interventions Propofol 0.5 mg/kg, with subsequent dose of 0.25 mg/kg and remifentanil 0.5 μg/kg, with subsequent dose 0.5 μg/kg compared with morphine 2.5 mg at 3‐minute increments with midazolam in 1‐mg increments every 3 minute
Outcomes
  • Time to full recovery

  • Operating conditions

  • Participant discomfort

Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote: "treatment was allocated in equal proportions (20 per group), to either morphine and midazolam or remifentanil and propofol by sequentially selecting sealed envelopes that had been shuffled and numbered"
Allocation concealment (selection bias) Low risk Quote: "treatment was allocated in equal proportions (20 per group), to either morphine and midazolam or remifentanil and propofol by sequentially selecting sealed envelopes that had been shuffled and numbered"
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Details included for all 40 participants completing study
Other bias Low risk Comment: no obvious "other bias" identified
Blinding of participants and personnel (performance bias) 
 All outcomes High risk No blinding reported
Blinding of outcome assessment (detection bias) 
 All outcomes High risk No blinding reported